Chunghwa Chemical Synthesis & Biotech Co., Ltd., Taiwan

Chunghwa Chemical Synthesis & Biotech (CCSB) - a product/ project-related co-operation partner for Active Pharmaceutical Ingredients.

The Company:
CCSB was founded in 1964 and is a member of the China Chemical Pharmaceutical Group.
Located in the suburban area of Taipei CCSB has been approved by the FDA since 1984. In 1997 CCSB upgraded their manufacturing facilities. Providing modern production facilities, a fully compliant cGMP trained personnel and a strong R&D team CCSB is in the position to offer both synthetic and biotech pharmaceutical products as well as innovative contract manufacturing services.

Specific Strengths:
For synthetic APIs and intermediates, CCSB is qualified to carry out a full range of organic synthesis (e.g. Acetylation, Addition, Alkylation, O-Alkylation, Amination, Ammonolysis, N-Carbamoylation, Chemical Resolution, Cyclization, Deamination, Decarboxylation, Dehydration, Diazotization, Epoxidation, Fisher Indole Synthesis, Hantzsch Pyridine Synthesis, Imination, Esterfication, Hydrolysis, Imine Exchange, Oxidation, Reduction, Ring Opening and other reactions upon request) in laboratory and scale-up.

For biotech APIs, CCSB is able to do Strain Improvement, Fermentation and Purification, Processes Development and Commercialization.

By its own sales office Pharmaports LLC, located in Montvale, New Jersey, USA, CCSB is in the position to provide firsthand service to the North American continent.